Sildenafil treatment prevents glomerular hypertension and hyperfiltration in rats with renal ablation

Kidney and Blood Pressure Research

Volumn 35, Issue 4, 2012, Pages 273-280

  Tapia, Edilia ^a   Sanchez Lozada, Laura G ^a   Soto, Virgilia ^a   Manrique, Andrés M ^a   Ortiz Vega, Karla M ^a   Santamara, José ^a   Medina Campos, Omar N ^a   Cristóbal, Magdalena ^a   Avila Casado, Carmen ^a   Pedraza Chaverri, José ^a   Rodríguez Iturbe, Bernardo ^b   Franco, Martha ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

Author keywords

5 6 nephrectomy; Arteriolopathy; cGMP; Glomerular hemodynamics; PDE5 inhibition; Sildenafil

Indexed keywords

CYCLIC GMP; HYDRALAZINE; HYDROCHLOROTHIAZIDE; NITRITE; NITROGEN DIOXIDE; RESERPINE; SILDENAFIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; HISTOPATHOLOGY; INTERSTITIAL NEPHRITIS; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY INJURY; KIDNEY SURGERY; MALE; MICROCIRCULATION; NEPHRECTOMY; NEPHRON; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; PUNCH BIOPSY; RAT; RENAL PROTECTION; RENOVASCULAR HYPERTENSION; SHAM PROCEDURE; URINARY EXCRETION;

ANIMALS; HYPERTENSION; KIDNEY GLOMERULUS; MALE; NEPHRECTOMY; PIPERAZINES; PURINES; RATS; RATS, WISTAR; SULFONES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84857486536     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000334952     Document Type: Article

References (34)

1. Rodríguez-Iturbe B, Garcia-Garcia G: The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin Pract 2010; 116:C81-C88.
2. Fine LG, Norman JT: Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 2008; 74: 867-872.
3. Vaziri ND, Ni Z, Oveisi F, Liang K, Pandian R: Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 2002; 39: 135-141.
4. Ingram A, Parbtani A, Thai K, Ly H, Shankland SJ, Morrissey G, Scholey JW: Dietary supplementation with L -arginine limits cell proliferation in the remnant glomerulus. Kidney Int 1995; 48: 1857-1865.
5. Hohenstein B, Daniel C, Wagner A, Stasch JP, Hugo C: Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis. Am J Physiol Renal Physiol 2005; 288:F685-F693.
6. Wang Y, Krämer S, Loof T, Martini S, Kron S, Kawachi H, Shimizu F, Neumayer HH, Peters H: Stimulation of soluble guanylate cyclase slows progression in anti-Thy1-induced chronic glomerulosclerosis. Kidney Int 2005; 68: 47-61.
7. Rodríguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Espinoza F, Pons H, Vaziri ND: Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. Kidney Int 2005; 68: 2131-2142.
8. Aboutabl ME, Raafat M, Maklad YA, Kenawy SA, El Din AG: Sildenafil augments the beneficial hemodynamic and histopathological effects of amlodipine in nitric oxide-deficient hypertensive rats: role of nitric oxidecyclic GMP pathway. Pharmacol Res 2008; 57: 456-463.
9. Hosogai N, Tomita M, Hamada K, Ogawa T, Hirosumi J, Manda T, Mutoh S: Phosphodiesterase type 5 inhibition ameliorates nephrotoxicity induced by cyclosporin A in spontaneous hypertensive rats. Eur J Pharmacol 2003; 477: 171-178.
10. Jeong KH, Lee TW, Ihm CG, Lee SH, Moon JY, Lim SJ: Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats. Am J Nephrol 2009; 29: 274-282.
11. Remuzzi G, Zoja C, Gagliardini E, Corna D, Abbate M, Benigni A: Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals. J Am Soc Nephrol 1999; 10: 1542-1549.
12. Tapia E, Franco M, Sánchez-Lozada LG, Soto V, Avila-Casado C, Santamaría J, Quiroz Y, Rodríguez-Iturbe B, Herrera-Acosta J: Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension. Kidney Int 2003; 63: 994-1002.
13. Fukumoto S, Koyama H, Hosoi M, Yamakawa K, Tanaka S, Morii H, Nishizawa Y: Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. Circ Res 1999; 85: 985-991.
14. Tantini B, Manes A, Fiumana E, Pignatti C, Guarnieri C, Zannoli R, Branzi A, Galieá N: Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells. Basic Res Cardiol 2005; 100: 131-138.
15. Raij L, Baylis C: Glomerular actions of nitric oxide. Kidney Int 1995; 48: 20-32.
16. Anderson S, Rennke HG, Brenner BM: Antihypertensive therapy must control glomerular hypertension to limit glomerular injury. J Hypertens Suppl 1986; 4:S242-S244.
17. Bartholomew B: A rapid method for the assay of nitrate in urine using the nitrate reductase enzyme of Escherichia coli . Food Chem Toxicol 1984; 22: 541-543.
18. Baylis C, Deen WM, Myers BD, Brenner BM: Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex. Am J Physiol 1976; 230: 1148-1158.
19. Davidson WD, Sackner MA: Simplification of the anthrone method for the determination of inulin in clearance studies. J Lab Clin Med 1963; 62: 351-356.
20. Vurek G, Pegram S: Fluorometric method for the determination of nanogram quantities of inulin. Anal Biochem 1966; 16: 409-419.
21. Viets JW, Deen WM, Troy JL, Brenner BM: Determination of serum protein concentration in nanoliter blood samples using fluorescamine or 9-phthalaldehyde. Anal Biochem 1978; 88: 513-521.
22. Henry RJ, Segalove M, Sobel C: Turbidimetric determination of proteins with sulfosalicylic and trichloroacetic acids. Proc Soc Exp Biol Med 1956; 92: 748-751.
23. Kim HJ, Vaziri ND, Norris K, An WF, Quiroz Y, Rodriguez-Iturbe B: High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease. Clin Exp Nephrol 2010; 14: 536-547.
24. Yaguas K, Bautista R, Quiroz Y, Ferrebuz A, Pons H, Franco M, Vaziri ND, Rodriguez-Iturbe B: Chronic sildenafil treatment corrects endothelial dysfunction and improves hypertension. Am J Nephrol 2010; 31: 283-291.
25. Gardiner SM, March JE, Kemp PA, Ballard SA, Hawkeswood E, Hughes B, Bennett T: Hemodynamic effects of phosphodiesterase 5 and angiotensin-converting enzyme inhibition alone or in combination in conscious SHR. J Pharmacol Exp Ther 2005; 312: 265-271.
26. Rossoni G, Manfredi B, De Gennaro V, Berti M, Guazzi M, Berti F: Sildenafil reduces L -NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat. Br J Pharmacol 2007; 150: 538-540.
27. Behr-Roussel D, Oudot A, Compagnie S, Gorny D, LeCoz O, Wayman C, Alexandre L, Giuliano F: Impact of a long-term sildenafil treatment on pressor response in conscious rats with insulin resistance and hypertriglyceridemia. Am J Hypertens 2008; 21: 1258-1263.
28. Koupparis AJ, Jeremy JY, Muzaffar S, Persad R, Shukla N: Sildenafil inhibits the formation of superoxide and the expression of GP47 NAD[P]H oxidase induced by the thromboxane A 2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int 2005; 96: 423-427.
29. Fernandes MA, Marques RJ, Vicente JA, Santos MS, Monteiro P, Moreno AJ, Custodio JB: Sildenafil citrate concentrations not affecting oxidative phosphorylation depress H 2 O 2 generation by rat heart mitochondria. Mol Cell Biochem 2008; 309: 77-85.
30. Ito S, Carretero OA, Abe K: Role of nitric oxide in the control of glomerular microcirculation. Clin Exp Pharmacol Physiol 1997; 24: 578-581.
31. Stotz WH, Li D, Johns RA: Exogenous nitric oxide upregulates p21(waf1/cip1) in pulmonary microvascular smooth muscle cells. J Vasc Res 2004; 41: 211-219.
32. Sharma K, Cook A, Smith M, Valancius C, Inscho EW: TGF- - impairs renal autoregulation via generation of ROS. Am J Physiol Renal Physiol 2005; 288:F1069-F1077.
33. Das A, Xi L, Kukreja RC: Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 2005; 280: 12994-12955.
34. Choi DE, Jeong JY, Lim BJ, Chung S, Chang YK, Lee SJ, Na KR, Kim SY, Shin YT, Lee KW: Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats. Am J Physiol Renal Physiol 2009; 297:F362-F370.